Hunan Er-Kang Pharmaceutical Co Ltd banner
H

Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267

Watchlist Manager
Hunan Er-Kang Pharmaceutical Co Ltd
SZSE:300267
Watchlist
Price: 4.02 CNY -1.71% Market Closed
Market Cap: ¥8.3B

Hunan Er-Kang Pharmaceutical Co Ltd
Investor Relations

Hunan Er-Kang Pharmaceutical Co., Ltd. engages in the research and development, production and sale of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 1,612 full-time employees. The company went IPO on 2011-09-27. The Company’s pharmaceutical excipients mainly consist of glycerol for medicine, sugar for medicine, ethanol for medicine, propylene glycol for medicine, as well as sodium hydroxide for medicine and others. Its bulk drugs consist of sulfadiazine, sulphaguanidine and resorcinol, among others. Its finished drugs consist of sulbenicillin sodium injections and compound liquorice tablets. The firm distributes its products in domestic market and to overseas markets.

Show more
Loading
300267
Shanghai Composite
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
No Earnings Calls Available

Management

Mr. Qingrong Sun
GM & Non-Independent Director
No Bio Available
Ms. Zhao Xun
CFO & Non Independent Director
No Bio Available
Ms. Xiangyang Shi
Deputy GM & Non Independent Director
No Bio Available
Mr. Jishun Gu
Deputy GM & Board Secretary
No Bio Available
Mr. Wang Hui
Deputy General Manager
No Bio Available

Contacts

Address
HUNAN
Changsha
No. 167, Kangping Road, Liuyang Economic Development Zone
Contacts
+8673183282597
www.hnerkang.com
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett